News for PetMed Express, Inc. (PETS)

U.S. stocks finished relatively flat Monday at the closing bell as investors largely brushed aside President Donald Trump's weekend announcement of new tariff

NEW YORK, July 14, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of PetMed Express, Inc. (”œPetMed” or the ”œCompa

PR NewswireNEW YORK, July 12, 2025 NEW YORK, July 12, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of PetMed Express,

NEW YORK, July 10, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of PetMed Express, Inc. (”œPetMed” or the ”œCompa

PR NewswireNEW YORK, July 7, 2025 NEW YORK, July 7, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of PetMed Express, In

DELRAY BEACH, Fla., July 03, 2025 (GLOBE NEWSWIRE) -- PetMed Express, Inc. (”œPetMeds®”) ( PETS) received on July 2, 2025, an expected notice (the ”œNoti

PetMed Express (PETS) has received a Nasdaq deficiency notice due to a delayed 10-K filing for the fiscal year ending March 31, 2025. The company has un

DELRAY BEACH, Fla., July 03, 2025 (GLOBE NEWSWIRE) -- PetMed Express, Inc. ('PetMeds®”) (NASDAQ: PETS) received on July 2, 2025, an expected notice (the 'Notice”) from The Nasdaq Stock Market LLC ('Nasdaq”) indicating that, as a result of not having timely filed its Annual Report on Form 10-K for the fiscal year ended March 31, 2025 (the 'Form 10-K”), with the Securities and Exchange Commission ('SEC”), the Company is not in compliance with Nasdaq Listing Rule 5250(c)(1) (the 'Listing Rule”), which requires timely filing of all required periodic financial reports with the SEC.

PR NewswireNEW YORK, July 2, 2025 NEW YORK, July 2, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of PetMed Express, In

NEW YORK, June 28, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of PetMed Express, Inc. (”œPetMed” or the ”œCompa

PetMed Express (PETS) is experiencing a typical level of options activity before its earnings announcement, with a significant preference for call options over

NEW YORK, June 23, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of PetMed Express, Inc. (”œPetMed” or the ”œCompa

PR NewswireNEW YORK, June 22, 2025 NEW YORK, June 22, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of PetMed Express,

NEW YORK, June 18, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of PetMed Express, Inc. (”œPetMed” or the ”œCompa

The major U.S. stock indexes surged on Monday, June 16, 2025, as investors appeared to shake off concerns about escalating Middle East tensions. The Dow Jones

PetMed Express anticipates a notable drop in Q4 2025 sales, projecting losses primarily due to tax valuation allowances. Analysts' average price target

DELRAY BEACH, Fla., June 16, 2025 (GLOBE NEWSWIRE) -- PetMed Express, Inc. dba PetMeds and parent company of PetCareRx ( PETS) today announced preliminary fou

Quarterly Revenue: Estimated to range from $51.1 million to $53.1 million, falling short of the $54.00 million estimate.Quarterly Net Loss: Estimated between $

PetMed Express (PETS) reports a significant decline in Q4 2025 net sales, estimating $51.1-53.1 million, down from $66.5 million year-over-year. FY 2025